Thus, the PAAD patients with low mRNA levels of the S100A1/B/Z or high mRNA levels of S100A2/A3/A5/A10/A11/A14/A16 were predicted to have worse OS. Here, S100A1 is linked to pancreatic adenocarcinoma.